Administered by a nurse with neonatal IV drug certification.
|
1 |
Burtin P, Jacqz-Aigrain E, Girard P, et al. Population pharmacokinetics
of midazolam in neonates. Clin Pharmacol Ther 1994;56:615-25
|
|
2 |
Jacqz-Aigrain E, Daoud P, Burtin P, Maherzi S, Beaufils F.
Pharmacokinetics of midazolam during continuous infusion in critically
ill neonates. Eur J Clin Pharmacol 1992;42(3):329-332
|
|
3 |
Harte GJ, Gray PH, Lee TC, Steer PA, Charles BG. Haemodynamic reponses
and population pharmacokinetics of midazolam following administration to
ventilated, preterm neonates. J Paediatr Child Health 1997;33(4):335-338
|
|
4 |
van Straarten HLM, Rademaker CMA, de Vries LS. Comparison of the effect
of midazolam or vecuronium on blood pressure and cerebral blood flow
velocity in the premature newborn. Dev Pharmacol Ther 1992;19:191-195.
|
|
5 |
Jacqz-Aigrain E, Daoud P, Burtin P, Desplanques L, Beaufils F.
Placebo-controlled trial of midazolam sedation in mechanically
ventilated newborn babies. Lancet 1994;344:646-650
|
|
6 |
Young TE, Magnum OB (eds). Neofax ‘95. A manual of drugs used in
neonatal care, ed 8. Columbus, Ohio: Ross Products Division, Abbott
Laboratories, USA, 1995, p136-7
|
|
7 |
Stockley I. Drug Interactions (4th ed). 1996.The Pharmaceutical Press.
London.
|
|
8 |
Young TE, Mangum OB. Neofax : A manual of drugs used in neonatal care
(ed 10). Raleigh, North Carolina: Acorn Publishing, USA, 1997, pp166-7.
|
|
9 |
Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for
sedation of infants in the neonatal intensive care unit. Cochrane
Systematic Review 2000 Issue 2. Update Software.
|